News and Events

Hatchtech positive DeOvo™ head lice Phase II clinical trial results

25/03/2010 | Press Releases

Hatchtech Pty Ltd confirms a successful Phase IIa clinical trial evaluating DeOvo™, an investigational proprietary drug being developed as a new topical treatment for head lice infestation.

Download PDF


Categories